{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:55:49Z","timestamp":1784919349848,"version":"3.55.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Sarcoidosis is a multisystemic granulomatosis diagnosed mainly in young adults. 18F-fluorodeoxyglucose (18F-FDG) PET\/CT is useful in sarcoidosis cases to search for a biopsiable site or assess disease activity.18F-FDG PET\/CT can reveal bone hypermetabolism in sarcoidosis patients, even in the absence of osteoarticular symptoms. The aim of this study was to describe metabolic bone involvement in sarcoidosis patients and to evaluate its prognostic impact.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was an observational, comparative, retrospective, monocentric study. Inclusion criteria were a confirmed diagnosis of sarcoidosis according to the World Association of Sarcoidosis and Other Granulomatous Diseases (WASOG) criteria and at least one 18F-FDG PET\/CT scan during follow-up. Metabolic bone involvement of sarcoidosis was defined as focal bone hypermetabolism with no argument for a differential diagnosis of bone 18F-FDG uptake. Patients with and without bone involvement were compared.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among the 175 included patients, 32 (18%) had metabolic bone involvement of sarcoidosis. The metabolic bone involvement was mainly axial and mostly without bone abnormalities on CT. Metabolic bone involvement was associated with intrathoracic and extrathoracic lymph node involvement and with a greater number of organs involved. Patients with metabolic bone involvement more frequently received corticosteroids, methotrexate and TNF-\u03b1 inhibitors and a greater number of treatments. Relapse of sarcoidosis occurred sooner in patients with metabolic bone involvement.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>These results suggest that metabolic bone involvement is associated with more diffuse and more severe sarcoidosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae019","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T01:14:22Z","timestamp":1705799662000},"page":"607-613","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic value of hypermetabolic bone sarcoidosis observed by 18F-fluorodeoxyglucose positron emission tomography"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1748-2555","authenticated-orcid":false,"given":"Arthur","family":"Bouchut","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Service de M\u00e9decine Interne 2, Centre National de R\u00e9f\u00e9rence Maladies Syst\u00e9miques Rares et Histiocytoses, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Lhote","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Service de M\u00e9decine Interne 2, Centre National de R\u00e9f\u00e9rence Maladies Syst\u00e9miques Rares et Histiocytoses, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Maksud","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Service de M\u00e9decine Nucl\u00e9aire, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thouraya","family":"Ben Salem","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Service de M\u00e9decine Interne 2, Centre National de R\u00e9f\u00e9rence Maladies Syst\u00e9miques Rares et Histiocytoses, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fustier","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Service de Radiologie, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0223-5191","authenticated-orcid":false,"given":"Quentin","family":"Moyon","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Service de M\u00e9decine Interne 2, Centre National de R\u00e9f\u00e9rence Maladies Syst\u00e9miques Rares et Histiocytoses, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Haroche","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Service de M\u00e9decine Interne 2, Centre National de R\u00e9f\u00e9rence Maladies Syst\u00e9miques Rares et Histiocytoses, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Soussan","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris 13, Assistance Publique-H\u00f4pitaux de Paris, Service de M\u00e9decine Nucl\u00e9aire, H\u00f4pital Universitaire Avicenne , Bobigny,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7653-6528","authenticated-orcid":false,"given":"Alexis","family":"Mathian","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Service de M\u00e9decine Interne 2, Centre National de R\u00e9f\u00e9rence Maladies Syst\u00e9miques Rares et Histiocytoses, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Hie","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Service de M\u00e9decine Interne 2, Centre National de R\u00e9f\u00e9rence Maladies Syst\u00e9miques Rares et Histiocytoses, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahir","family":"Amoura","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Service de M\u00e9decine Interne 2, Centre National de R\u00e9f\u00e9rence Maladies Syst\u00e9miques Rares et Histiocytoses, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Cohen Aubart","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Assistance Publique-H\u00f4pitaux de Paris, Service de M\u00e9decine Interne 2, Centre National de R\u00e9f\u00e9rence Maladies Syst\u00e9miques Rares et Histiocytoses, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re , Paris,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,19]]},"reference":[{"key":"2025032905205168500_keae019-B1","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"2025032905205168500_keae019-B2","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"key":"2025032905205168500_keae019-B3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-199903000-00001","article-title":"The clinical management of sarcoidosis a 50-year experience at the Johns Hopkins hospital","volume":"78","author":"Johns","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"2025032905205168500_keae019-B4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/RLU.0b013e3182335f9b","article-title":"F-18 FDG PET\/CT for detecting bone and bone marrow involvement in sarcoidosis patients","volume":"37","author":"Mostard","year":"2012","journal-title":"Clin Nucl Med"},{"key":"2025032905205168500_keae019-B5","first-page":"149","article-title":"American Thoracic Society\/European Respiratory Society\/World association of sarcoidosis and other granulomatous disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"key":"2025032905205168500_keae019-B6","first-page":"44","article-title":"Volumetric FDG PET analysis of global lung inflammation: new tool for precision medicine in pulmonary sarcoidosis?","volume":"35","author":"Adams","year":"2018","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"key":"2025032905205168500_keae019-B7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front Immunol"},{"key":"2025032905205168500_keae019-B8","first-page":"1647","article-title":"Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis","volume":"35","author":"Lewis","year":"1994","journal-title":"J Nucl Med Off. Publ Soc Nucl Med"},{"key":"2025032905205168500_keae019-B9","first-page":"241","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"2025032905205168500_keae019-B10","first-page":"1741","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"key":"2025032905205168500_keae019-B11","first-page":"2135","article-title":"18F-FDG uptake of the right ventricle is an important predictor of histopathologic diagnosis by endomyocardial biopsy in patients with cardiac sarcoidosis","volume":"27","author":"Omote","year":"2020","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol"},{"key":"2025032905205168500_keae019-B12","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med"},{"key":"2025032905205168500_keae019-B13","first-page":"123","article-title":"18F-FDG PET as a predictor of pulmonary function in sarcoidosis","volume":"28","author":"Keijsers","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"key":"2025032905205168500_keae019-B14","first-page":"1543","article-title":"The utility of 18F-FDG PET\/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis","volume":"53","author":"Sobic-Saranovic","year":"2012","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"2025032905205168500_keae019-B15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13550-019-0505-x","article-title":"Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET\/CT: SUVmax versus total lung glycolysis","volume":"9","author":"Schimmelpennink","year":"2019","journal-title":"EJNMMI Res"},{"key":"2025032905205168500_keae019-B16","doi-asserted-by":"crossref","first-page":"E890","DOI":"10.3390\/jcm9030890","article-title":"In which patients with sarcoidosis is FDG PET\/CT indicated?","volume":"9","author":"Keijsers","year":"2020","journal-title":"J Clin Med"},{"key":"2025032905205168500_keae019-B17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/17476348.2020.1682997","article-title":"18F-FDG PET\/CT in pulmonary sarcoidosis: quantifying inflammation by the TLG index","volume":"14","author":"Papiris","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"2025032905205168500_keae019-B18","first-page":"66","article-title":"FDG PET\/CT in bone sarcoidosis","volume":"33","author":"Grozdic Milojevic","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"key":"2025032905205168500_keae019-B19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.semarthrit.2017.02.004","article-title":"Clinical characteristics of patients with bone sarcoidosis","volume":"47","author":"Zhou","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2025032905205168500_keae019-B20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jbspin.2019.07.009","article-title":"Osseous sarcoidosis: a multicenter retrospective case-control study of 48 patients","volume":"86","author":"Ben Hassine","year":"2019","journal-title":"Joint Bone Spine"},{"key":"2025032905205168500_keae019-B21","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1007\/s10067-020-05022-6","article-title":"18F-FDG PET\/CT in bone sarcoidosis: an observational study","volume":"39","author":"Demaria","year":"2020","journal-title":"Clin. Rheumatol"},{"key":"2025032905205168500_keae019-B22","first-page":"215","article-title":"Sarcoidosis of bone","volume":"46","author":"Neville","year":"1977","journal-title":"Q J Med"},{"key":"2025032905205168500_keae019-B23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00002281-200007000-00016","article-title":"Bone sarcoidosis","volume":"12","author":"Wilcox","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"2025032905205168500_keae019-B24","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00296-015-3341-y","article-title":"Bone and bone marrow involvement in sarcoidosis","volume":"35","author":"Yachoui","year":"2015","journal-title":"Rheumatol Int"},{"key":"2025032905205168500_keae019-B25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/rheumatology\/kex317","article-title":"A review of the musculoskeletal manifestations of sarcoidosis","volume":"57","author":"Bechman","year":"2018","journal-title":"Rheumatology (Oxf Engl)"},{"key":"2025032905205168500_keae019-B26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.semarthrit.2014.07.003","article-title":"Osseous sarcoidosis: clinical characteristics, treatment, and outcomes\u2014experience from a large, academic hospital","volume":"44","author":"Sparks","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"2025032905205168500_keae019-B27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.RLU.0000053528.35645.70","article-title":"Unsuspected skeletal sarcoidosis mimicking metastatic disease on FDG positron emission tomography and bone scintigraphy","volume":"28","author":"Ludwig","year":"2003","journal-title":"Clin Nucl Med"},{"key":"2025032905205168500_keae019-B28","first-page":"525","article-title":"Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients","volume":"52","author":"Neville","year":"1983","journal-title":"Q J Med"},{"key":"2025032905205168500_keae019-B29","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"key":"2025032905205168500_keae019-B30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/17476348.2020.1775587","article-title":"Prevalence, distribution and clinical significance of joints, muscles and bones in sarcoidosis: an 18F-FDG-PET\/CT study","volume":"14","author":"Papiris","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"2025032905205168500_keae019-B31","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1055\/s-2007-1006297","article-title":"Osseous sarcoidosis","volume":"13","author":"Rohatgi","year":"1992","journal-title":"Semin Respir Crit Care Med"},{"key":"2025032905205168500_keae019-B32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-2002-36520","article-title":"Sarcoidosis involving the musculoskeletal system","volume":"23","author":"Zisman","year":"2002","journal-title":"Semin Respir Crit Care Med"},{"key":"2025032905205168500_keae019-B33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12149-009-0286-9","article-title":"A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity","volume":"23","author":"Inoue","year":"2009","journal-title":"Ann Nucl Med"},{"key":"2025032905205168500_keae019-B34","first-page":"1155","article-title":"Diseases showing diffuse bone uptake on FDG-PET","volume":"60","author":"Inukai","year":"2019","journal-title":"J Nucl Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae019\/56438197\/keae019.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/607\/56438197\/keae019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/2\/607\/56438197\/keae019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:23:38Z","timestamp":1743391418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/2\/607\/7582294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,19]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,19]]},"published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae019","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,1,19]]}}}